Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Balchem (BCPC) Common Equity (2016 - 2026)

Balchem (BCPC) has disclosed Common Equity for 17 consecutive years, with $1.3 billion as the latest value for Q1 2026.

  • For Q1 2026, Common Equity rose 6.32% year-over-year to $1.3 billion; the TTM value through Mar 2026 reached $1.3 billion, up 6.32%, while the annual FY2025 figure was $1.3 billion, 9.35% up from the prior year.
  • Common Equity hit $1.3 billion in Q1 2026 for Balchem, up from $1.3 billion in the prior quarter.
  • Across five years, Common Equity topped out at $1.3 billion in Q3 2025 and bottomed at $873.7 million in Q1 2022.
  • Average Common Equity over 5 years is $1.1 billion, with a median of $1.1 billion recorded in 2024.
  • Year-over-year, Common Equity increased 0.77% in 2022 and then grew 14.82% in 2024.
  • Balchem's Common Equity stood at $938.3 million in 2022, then rose by 12.33% to $1.1 billion in 2023, then rose by 9.1% to $1.1 billion in 2024, then increased by 9.35% to $1.3 billion in 2025, then increased by 2.2% to $1.3 billion in 2026.
  • According to Business Quant data, Common Equity over the past three periods came in at $1.3 billion, $1.3 billion, and $1.3 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.